Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 8,501–8,525 of 27,380 studies, newest first · page 341 of 1096.

September 2022 22

  1. 2022-09-05

    Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study

    ✓ Peer-reviewed Biomarkers Journal of neuroinflammation

    Key finding: CSF C1q and C3b, as well as plasma C2 and C3, were elevated in symptomatic mutation carriers compared to presymptomatic carriers and non-carriers. +4 more findings

  2. 2022-09-05

    Unsupervised high-frequency smartphone-based cognitive assessments are reliable, valid, and feasible in older adults at risk for Alzheimer's disease

    ✓ Peer-reviewed Cognitive tests and assessment Journal of the International Neuropsychological Society : JINS

    Key finding: Overall, the results suggest that ARC is reliable and valid and represents a feasible tool for assessing cognitive changes associated with the earliest stages of AD. +3 more findings

  3. 2022-09-05

    Depression, Depression Treatments, and Risk of Incident Dementia: A Prospective Cohort Study of 354,313 Participants

    ✓ Peer-reviewed Prevention and risk Biological Psychiatry

    Key finding: The negative association between depression treatment and incident dementia was significant in the increasing and chronically low courses, highlighting the necessity of timely interventional strategies before depression progresses to a chronically severe state. +3 more findings

  4. 2022-09-03

    LATE-NC aggravates GVD-mediated necroptosis in Alzheimer's disease

    ✓ Peer-reviewed Brain tissue and pathology Acta neuropathologica communications

    Key finding: Recently, we found that all proteins required for necroptosis execution, a previously defined programmed form of neuronal cell death, are present in GVD, such as the phosphorylated necroptosis executioner mixed-lineage kinase domain-like protein (pMLKL). +4 more findings

  5. 2022-09-03

    Active immunotherapy against pathogenic Cis pT231-tau suppresses neurodegeneration in traumatic brain injury mouse models

    ✓ Peer-reviewed Drug development Neuropeptides

    Key finding: Traumatic brain injury (TBI), characterized by acute neurological impairment, is associated with a higher incidence of neurodegenerative diseases, particularly chronic traumatic encephalopathy (CTE), Alzheimer's disease (AD), and Parkinson's disease (PD), whose hallmarks include hyperphosphorylated tau protein. +2 more findings

  6. 2022-09-02

    Providers' Perspectives on High-Quality Dementia Care in Long-Term Care

    ✓ Peer-reviewed Health systems and care delivery Journal of the American Medical Directors Association

    Key finding: The 9 participants described the importance of understanding the experiences of PLWDs in order to provide high-quality dementia care and to deliver such care with the residents and their preferences as the focus. +4 more findings

  7. 2022-09-02

    Optimal anti-amyloid-beta therapy for Alzheimer's disease via a personalized mathematical model

    ✓ Peer-reviewed Treatments PLoS computational biology

    Key finding: With the recent approval by the FDA of the first disease-modifying drug for Alzheimer's Disease (AD), personalized medicine will be increasingly important for appropriate management and counseling of patients with AD and those at risk.

  8. 2022-09-02

    The therapeutic potential of TREM2 in cancer

    ✓ Peer-reviewed TREM2 and immune genetics Frontiers in oncology

    Key finding: However, expansion of TREM2 research into the field of cancer has revealed that epithelial tumor cells as well as intratumoral macrophages and myeloid regulatory cells also express TREM2. +1 more finding

  9. 2022-09-02

    Trem2 deletion enhances tau dispersion and pathology through microglia exosomes

    ✓ Peer-reviewed TREM2 and immune genetics Molecular neurodegeneration

    Key finding: Variants in the microglial immune receptor TREM2 are associated with enhanced risk of onset in sporadic Alzheimer's disease (AD). +3 more findings

  10. 2022-09 month only

    Enteric nervous system and intestinal epithelial regulation of the gut-brain axis

    ✓ Peer-reviewed Disease mechanisms The Journal of allergy and clinical immunology

    Key finding: This interplay provides a link between exogenous environmental stimuli such as nutrient sensing, and nervous system function, as well as a mechanism of feedback from cortical and sensory centers of the brain to enteric activities. +4 more findings

  11. 2022-09 month only

    Ethics of digital therapeutics (DTx)

    ✓ Peer-reviewed Prevention and risk European review for medical and pharmacological sciences

    Key finding: Today, there are roughly 35 to 40 products on the market, 8 of which approved by regulatory agencies. +4 more findings

  12. 2022-09 month only
  13. 2022-09-01

    Artificial intelligence in dementia

    ✓ Peer-reviewed Brain scans and imaging Current opinion in ophthalmology

    Key finding: Artificial intelligence tools are being rapidly integrated into clinical environments and may soon be incorporated into dementia diagnostic paradigms. +4 more findings

  14. 2022-09 month only

    A literature review of hypertensive retinopathy: systemic correlations and new technologies

    ✓ Peer-reviewed Brain scans and imaging European review for medical and pharmacological sciences

    Key finding: HR signs have a significative association with cardiovascular, cerebrovascular and other systemic diseases. +4 more findings

  15. 2022-09 month only

    Abnormal characterization of dynamic functional connectivity in Alzheimer's disease

    ✓ Peer-reviewed Brain scans and imaging Neural regeneration research

    Key finding: We found differences in dynamic function connectivity strength in the left precuneus, default mode network, and dorsal attention network among normal controls, aMCI patients, and AD patients.

  16. 2022-09-01

    Blood DNA Methylation Patterns in Older Adults With Evolving Dementia

    ✓ Peer-reviewed Genetics The journals of gerontology. Series A, Biological sciences and medical sciences

    Key finding: Reflecting this, epigenetic alterations have been associated with each of these processes, especially at the level of DNA methylation, and such changes may help explain the observed interindividual variability in the development of the 2 pathologies. +3 more findings

  17. 2022-09-01
  18. 2022-09-01

    Post‐acute care transitions and outcomes among Medicare beneficiaries with dementia: Associations with race/ethnicity and dual status

    ✓ Peer-reviewed Risk factors Health Services Research

    Key finding: Dual-related differences were significantly larger than race/ethnicity differences in PAC transitions. +4 more findings

  19. 2022-09-01
  20. 2022-09-01

    Role of Microglia and Astrocytes in Alzheimer's Disease: From Neuroinflammation to Ca2+ Homeostasis Dysregulation

    ✓ Peer-reviewed Inflammation and the immune system Cells

    Key finding: Cerebral atrophy, amyloid-β (Aβ) plaques, and neurofibrillary tangles represent the main pathological hallmarks of the AD brain. +3 more findings

  21. 2022-09-01

    Joint Genetic Inhibition of PCSK9 and CETP and the Association With Coronary Artery Disease: A Factorial Mendelian Randomization Study

    ✓ Peer-reviewed Long-term cohort studies JAMA cardiology

    Key finding: Cholesteryl ester transfer protein inhibition (CETP) has been shown to increase levels of high-density lipoprotein cholesterol (HDL-C) and reduce levels of low-density lipoprotein cholesterol (LDL-C). +3 more findings

  22. 2022-09-01

    Association of Multimorbidity, Disease Clusters, and Modification by Genetic Factors With Risk of Dementia

    ✓ Peer-reviewed Long-term cohort studies JAMA network open

    Key finding: Individual conditions have been identified as risk factors for dementia; however, it is important to consider the role of multimorbidity, as conditions often co-occur. +3 more findings

August 2022 3

  1. 2022-08-31

    Social participation and mild cognitive impairment in low- and middle-income countries

    ✓ Peer-reviewed Risk factors Preventive medicine

    Key finding: In the overall sample, after adjustment for potential confounders, a one-unit increase in the social participation score was associated with a 13% decrease in odds for MCI (OR = 0.87; 95%CI = 0.82-0.93). +1 more finding

  2. 2022-08-31

    Apolipoprotein E in Cardiometabolic and Neurological Health and Diseases

    ✓ Peer-reviewed Genetics International journal of molecular sciences

    Key finding: The human APOE gene is polymorphic with three major alleles, ε2, ε3 and ε4, encoding apoE2, apoE3, and apoE4, respectively. +4 more findings

  3. 2022-08-31

    Global, regional, and national trends of dementia incidence and risk factors, 1990-2019: A Global Burden of Disease study

    ✓ Peer-reviewed Risk factors Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: The declining incidence of dementia in some countries, despite growing prevalence, is encouraging and urges further investigation. +1 more finding

Browse the library by subject, with the full score breakdown →